DAVI Stock Forecast: Davion Healthcare Plc Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 10 of 100 as at 4 Nov 2026 — in the weakest quartile.
DAVI stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores Davion Healthcare Plc on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Size (82): Smaller than most of the companies we track.
Momentum (0): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
DAVI stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on DAVI, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
DAVI appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
DAVI analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Davion Healthcare Plc (DAVI) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- —
- Price / book
- 0.5×
- EV / EBITDA
- —
Cheaper than 82% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- —
- Operating margin
- 0.0%
- Net margin
- 0.0%
Higher than 32% of US stocks
Higher than 30% of US stocks
- Return on equity
- −1.3%
- Return on assets
- −0.8%
- Dividend yield
- 0.0%
Higher than 43% of US stocks
Higher than 40% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
Davion Healthcare Plc (DAVI) statistics: revenue, profit & scale
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Davion Healthcare Plc has a market value of $38.5M and an enterprise value of $44.1M.
Forward dividend yield: 0.00%.
Davion Healthcare Plc employs 0 people.
Data provided by Twelve Data
DAVI vs competitors
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Davion Healthcare Plc — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Frequently asked questions about DAVI stock
How does Ticker Nerd's model rank DAVI?
As at 4 Nov 2026, Davion Healthcare Plc ranks 10 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (82 of 100).
What is the DAVI stock forecast for 2030?
No analyst covering Davion Healthcare Plc publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for DAVI are extrapolating price history, which says nothing about the business.
What does Davion Healthcare Plc do?
Davion Healthcare Plc is a digital healthcare company developing and commercializing non-invasive technologies for at-home health monitoring and early anomaly detection. Its product portfolio includes BreastCheck, a home-based breast health screening device designed to identify temperature variations that may warrant further clinical assessment; FootFlow, which monitors indicators associated with circulation and diabetes-related blood-flow concerns; Testic, an at-home testicular health monitoring system; and ThermaDerm, focused on detecting skin anomalies.
About Davion Healthcare Plc.
Davion Healthcare Plc is a digital healthcare company developing and commercializing non-invasive technologies for at-home health monitoring and early anomaly detection. Its product portfolio includes BreastCheck, a home-based breast health screening device designed to identify temperature variations that may warrant further clinical assessment; FootFlow, which monitors indicators associated with circulation and diabetes-related blood-flow concerns; Testic, an at-home testicular health monitoring system; and ThermaDerm, focused on detecting skin anomalies. The company also offers WoundSkan, a battery-free dressing that uses smartphone-based imaging to monitor wound temperature, alongside the Spektra Lateral Flow Test, a rapid multi-marker screening platform. These products combine visual temperature-sensitive materials, smartphone imaging, and digital analysis to support preventive healthcare and earlier clinical follow-up. Headquartered in County Cork, Ireland, Davion Healthcare Plc operates within the medical devices and digital health markets, serving consumers, healthcare providers, and organizations seeking accessible monitoring tools outside traditional clinical settings.
Ireland · https://www.davionhealthcare.com